<--- Back to Details
First PageDocument Content
Chemistry / Gentamicin / Tobramycin / Aminoglycoside / Amikacin / Fusidic acid / Ototoxicity / Therapeutic drug monitoring / Pharmaceutical drug / Aminoglycoside antibiotics / Medicine / Pharmacology
Date: 2014-11-18 22:42:20
Chemistry
Gentamicin
Tobramycin
Aminoglycoside
Amikacin
Fusidic acid
Ototoxicity
Therapeutic drug monitoring
Pharmaceutical drug
Aminoglycoside antibiotics
Medicine
Pharmacology

Add to Reading List

Source URL: www.ciap.health.nsw.gov.au

Download Document from Source Website

File Size: 866,50 KB

Share Document on Facebook

Similar Documents

Therapeutic Drug Monitoring Immunoassay for Efavirenz Kenneth C. Kasper1, Joanne Valencia1, Ki Chung1, Byung Sook Moon1, Johnny Valdez1, Anura Jayewardene2, Patricia Lizak2, and Francesca T. Aweeka2 ARK Diagnostics, Inc.

DocID: 1uWz5 - View Document

Sponsorship and exhibition prospectus International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) Congress 2018

DocID: 1uIsL - View Document

The ARK EFV-TestTM: A Rapid, Automated Immunoassay for Therapeutic Drug Monitoring of Efavirenz Michael K. Helms1, Diane T. Holland2, Rowena J. Espina-Quinto2, Ellen K. Stefanski2, Byung S. Moon1, Johnny J. Valdez1, and

DocID: 1u0vo - View Document

TNFα Blockers ELISA Kits Toolsets for drug-level testing Monitoring therapeutic drug levels is crucial to optimize therapy for patients treated with biologicals. Treatment with TNFα blockers can be hampered by antibody

DocID: 1tnQk - View Document

First Announcement Therapeutic Drug Monitoring: Current Status and Future Directions Symposium organized by the working group „Drugs“ of the Swiss Society for Clinical Chemistry Auditorium ETtore Rossi, Inselspita

DocID: 1q0nC - View Document